Percutaneous Transluminal Angioplasty (PTA) Alone versus PTA with Balloon-expandable Stent Placement for Short-segment Femoropopliteal Artery Disease: A Metaanalysis of Randomized Trials

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 4, 2008, Pages 499-503

  E, YaJun ^a   He, NengShu ^a   Wang, Yi ^a   Fan, HaiLun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; FEMOROPOPLITEAL ARTERY OCCLUSIVE DISEASE; GRAFT PATENCY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; STENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; LEG; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TREATMENT OUTCOME;

EID: 41149161107     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.12.446     Document Type: Article

References (17)

1. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of angioplasty. Radiology 183 (1992) 767-771
2. Rogers C., and Edelman E.R. Pushing drug-eluting stents into uncharted territory: simpler than you think-more complex than you imagine. Circulation 113 (2006) 2262-2265
3. Maisel W.H. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984
4. Shuchman M. Trading restenosis for thrombosis?. New questions about drug-eluting stents. N Engl J Med 355 (2006) 1949-1952
5. Lichtenstein M.J., Mulrow C.D., and Elwood P.C. Guidelines for reading case-control studies. J Chron Dis 40 (1987) 893-903
6. Zdanowski Z., Albrechtsson U., Lundin A., et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions?. A randomized controlled study. Int Angiol 18 (1999) 251-255
7. Cejna M., Schoder M., and Lammer J. PTA vs. stent in femoro-popliteal obstruction. Radiologe 39 (1999) 144-150
8. Grimm J., Müller-Hülsbeck S., Jahnke T., Hilbert C., Brossmann J., and Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 12 (2001) 935-942
9. Cejna M., Thurnher S., Illiasch H., et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 12 (2001) 23-31
10. Pozzi Mucelli F., Fisicaro M., Calderan L., et al. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent: results after six years' follow-up. Radiol Med (Torino) 105 (2003) 339-349
11. Grenacher L., Saam T., Geier A., et al. PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA). Rofo 176 (2004) 1302-1310
12. Rand T., Basile A., Cejna M., et al. PTA versus Carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 29 (2006) 29-38
13. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
14. Krankenberg H., Schlüter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 116 (2007) 285-292
15. Linsun L. Clinical Interventional Therapy (1994), Jiangsu Scientific and Technical Publishers, Nanjing, China
16. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
17. Schillinger M., and Minar E. Endovascular stent implantation for treatment of peripheral artery disease. Eur J Clin Invest 37 (2007) 165-170